{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:23:01Z","timestamp":1773296581579,"version":"3.50.1"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,20]]},"DOI":"10.18632\/oncotarget.11404","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T21:29:00Z","timestamp":1471642140000},"page":"62240-62254","source":"Crossref","is-referenced-by-count":24,"title":["Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Nooshin","family":"Mirkheshti","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulgi","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoulei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie","family":"Cropper","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry L.","family":"Werner","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung S.","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandana","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA"},{"name":"South Texas Veterans Health Care System, San Antonio, Texas 78229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"x251","DOI":"10.1093\/annonc\/mds325","article-title":"Non-metastatic CRPC and asymptomatic metastatic CRPC: which treatment for which patient?","volume":"23","author":"Tombal","year":"2012","journal-title":"Ann Oncol"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.0829","article-title":"Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer","author":"Kantoff","year":"2015","journal-title":"JAMA Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.coph.2008.07.005","article-title":"Targeting the androgen receptor pathway in prostate cancer","volume":"8","author":"Scher","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"4","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth","volume":"68","author":"Nelson","year":"2008","journal-title":"Cancer Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and Increased Survival in Metastatic Prostate Cancer","volume":"364","author":"Harland","year":"2011","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Fl\u00e9chon","year":"2012","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7150\/ijbs.8780","article-title":"Roles for the Backdoor Pathway of Androgen Metabolism in Prostate Cancer Response to Castration and Drug Treatment","volume":"10","author":"Mohler","year":"2014","journal-title":"Int J Biol Sci"},{"key":"8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/CMAR.S39318","article-title":"Abiraterone in the treatment of metastatic castration-resistant prostate cancer","volume":"6","author":"Mostaghel","year":"2014","journal-title":"Cancer Management and Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer","volume":"373","author":"Flohr","year":"2015","journal-title":"N Eng J Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Landers","year":"2010","journal-title":"Cancer Cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Sonenberg","year":"2004","journal-title":"Genes Dev"},{"key":"12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1126\/science.aad9696","article-title":"Seeing mTORC1 specificity","volume":"351","author":"Blenis","year":"2016","journal-title":"Science"},{"key":"14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Shaw","year":"2011","journal-title":"Nat Cell Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ccr.2011.05.006","article-title":"Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth","volume":"19","author":"Wu","year":"2011","journal-title":"Cancer Cell"},{"key":"16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","article-title":"Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer","volume":"19","author":"Sawyers","year":"2011","journal-title":"Cancer Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1158\/1535-7163.MCT-13-0032","article-title":"Synergistic Targeting of PI-3K\/AKT Pathway and Androgen Receptor Axis Significantly Delays Castration-Resistant Prostate Cancer Progression","volume":"12","author":"Zoubeidi","year":"2013","journal-title":"Mol Cancer Therapeut"},{"key":"18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1464-410X.2012.11456.x","article-title":"Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer","volume":"110","author":"Taplin","year":"2012","journal-title":"Br J Urol Int"},{"key":"19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbrc.2011.08.054","article-title":"Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization","volume":"413","author":"Ahn","year":"2011","journal-title":"Biochim Biophys Res Commun"},{"key":"20","first-page":"23","article-title":"Gene Expression Profiling from a Prostate Cancer PC-3 Cell Line Treated with Salinomycin Predicts Cell Cycle Arrest and Endoplasmic Reticulum Stress","volume":"5","author":"Ahn","year":"2013","journal-title":"J Cancer Sci & Ther"},{"key":"21","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1158\/0008-5472.CAN-05-4472","article-title":"Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and posttranscriptional increases in cyclin D proteins","volume":"66","author":"Balk","year":"2006","journal-title":"Cancer Res"},{"key":"22","first-page":"3895","article-title":"Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival","volume":"30","author":"IP","year":"2010","journal-title":"Anticancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/jcb.24850","article-title":"Salinomycin suppresses LRP6 expression and inhibits both Wnt\/\u03b2-catenin and mTORC1 signaling in breast and prostate cancer cells","volume":"115","author":"Li","year":"2014","journal-title":"J Cell Biochem"},{"key":"24","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jcb.24455","article-title":"Interplay of reactive oxygen species, intracellular Ca2+ surge and loss of mitochondrial homeostasis in the apoptotic ablation of prostate cancer cells by deoxypodophyllotoxin","volume":"114","author":"Ahn","year":"2013","journal-title":"J Cell Biochem"},{"key":"25","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1210\/me.2004-0117","article-title":"Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells","volume":"18","author":"Chang","year":"2004","journal-title":"Mol Endocrinol"},{"key":"26","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1038\/onc.2008.318","article-title":"Regulation of andogen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival","volume":"27","author":"Ghosh","year":"2008","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1210\/me.2012-1369","article-title":"Sulfotransferase SULT2B1b: Induction by vitamin D receptor, loss of expression in prostate cancer","volume":"27","author":"Chatterjee","year":"2013","journal-title":"Mol Endocrinol"},{"key":"28","doi-asserted-by":"crossref","first-page":"43940","DOI":"10.1074\/jbc.M404421200","article-title":"Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo: Role of mitochondrial reactive nitrogen species","volume":"279","author":"Goldman","year":"2004","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1189\/jlb.0312123","article-title":"Transient receptor potential vanilloid 1activation induces autophagy in thymocytes through ROS-regulated AMPK and Atg4C pathways","volume":"92","author":"Santoni","year":"2012","journal-title":"J Leukocyte Biol"},{"key":"30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Shaw","year":"2008","journal-title":"Mol Cell"},{"key":"31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Guan","year":"2002","journal-title":"Nat Cell Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: the mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Hall","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1158\/0008-5472.CAN-08-4385","article-title":"Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a-deficient mouse model of prostate cancer","volume":"69","author":"Majumdar","year":"2009","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"E2572","DOI":"10.1073\/pnas.1304318110","article-title":"Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer","volume":"110","author":"Gorgulu","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"35","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1091\/mbc.e08-12-1248","article-title":"Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy","volume":"20","author":"Mizushima","year":"2009","journal-title":"Mol Biol Cell"},{"key":"36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cmet.2011.01.009","article-title":"AMPK-dependent phosphorylation of ULK1 induces autophagy","volume":"13","author":"Klionsky","year":"2011","journal-title":"Cell Metab"},{"key":"37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Guan","year":"2011","journal-title":"Nat Cell Biol"},{"key":"38","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1038\/ncomms9048","article-title":"Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A","volume":"6","author":"Jiang","year":"2015","journal-title":"Nature Communs"},{"key":"39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/emboj.2011.12","article-title":"AMPK and autophagy get connected","volume":"30","author":"Hardie","year":"2011","journal-title":"Embo J"},{"key":"40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4161\/auto.24632","article-title":"Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells","volume":"9","author":"Liu","year":"2013","journal-title":"Autophagy"},{"key":"41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/0008-5472.CAN-13-2966","article-title":"The Four Faces of Autophagy: Implications for Cancer Therapy","volume":"74","author":"Gewirtz","year":"2014","journal-title":"Cancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/cdd.2014.143","article-title":"Autosis and autophagic cell death: the dark side of autophagy","volume":"22","author":"Levine","year":"2015","journal-title":"Cell Death Differ"},{"key":"43","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Thompson","year":"2013","journal-title":"Oncogene"},{"key":"44","doi-asserted-by":"crossref","first-page":"29304","DOI":"10.1074\/jbc.M204131200","article-title":"Androgen receptor phosphorylation: Regulation and identification of the phosphorylation sites","volume":"277","author":"Weber","year":"2002","journal-title":"J Biol Chem"},{"key":"45","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1210\/me.2010-0238","article-title":"CDK9 regulates AR promoter selectivity and cell growth through serine-81 phosphorylation","volume":"24","author":"Gioeli","year":"2010","journal-title":"Mol Endocrinol"},{"key":"46","doi-asserted-by":"crossref","first-page":"33141","DOI":"10.1074\/jbc.M111.252080","article-title":"Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5","volume":"286","author":"Lin","year":"2011","journal-title":"J Biol Chem"},{"key":"47","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1074\/jbc.M111.325290","article-title":"Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation","volume":"287","author":"Balk","year":"2012","journal-title":"J Biol Chem"},{"key":"48","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.4161\/cc.21730","article-title":"Androgen receptor serine 81 mediates Pin1 interaction and activity","volume":"11","author":"Giordano","year":"2012","journal-title":"Cell Cycle"},{"key":"49","doi-asserted-by":"crossref","first-page":"25576","DOI":"10.1074\/jbc.M109.043133","article-title":"Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase1","volume":"284","author":"Balk","year":"2009","journal-title":"J Biol Chem"},{"key":"50","first-page":"3065","article-title":"Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer","volume":"118","author":"Cantley","year":"2008","journal-title":"J Clin Invest"},{"key":"51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening","volume":"138","author":"Lander","year":"2009","journal-title":"Cell"},{"key":"52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1476-4598-13-16","article-title":"Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration","volume":"13","author":"Roidl","year":"2014","journal-title":"Mol Cancer"},{"key":"53","doi-asserted-by":"publisher","first-page":"10134","DOI":"10.18632\/oncotarget.3548","article-title":"Glucose starvation-mediated inhibition of salinomycin-induced autophagy amplifies cancer cell specific cell death","volume":"6","author":"Los","year":"2015","journal-title":"Oncotarget"},{"key":"54","doi-asserted-by":"publisher","first-page":"950658","DOI":"10.1155\/2012\/950658","article-title":"Salinomycin as a Drug for Targeting Human Cancer Stem Cells","volume":"2012","author":"Steinhart","year":"2012","journal-title":"J Biomed Biotech"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T11:52:34Z","timestamp":1589284354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":54,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,9,20]]}},"alternative-id":["11404","27557496"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11404","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,19]]}}}